Most Popular
-
1
Dongduk Women’s University halts coeducation talks
-
2
Defense ministry denies special treatment for BTS’ V amid phone use allegations
-
3
Russia sent 'anti-air' missiles to Pyongyang, Yoon's aide says
-
4
OpenAI in talks with Samsung to power AI features, report says
-
5
Two jailed for forcing disabled teens into prostitution
-
6
Trump picks ex-N. Korea policy official as his principal deputy national security adviser
-
7
South Korean military plans to launch new division for future warfare
-
8
S. Korea not to attend Sado mine memorial: foreign ministry
-
9
Kia EV9 GT marks world debut at LA Motor Show
-
10
Gold bars and cash bundles; authorities confiscate millions from tax dodgers
Samsung Biologics Co. on Tuesday reported its fourth-quarter net profit of 96.2 billion won ($87 million), down 54.3 percent from a year earlier.
The company said in a regulatory filing that operating income for the October-December period fell 13.4 percent on-year to 92.6 billion won. Sales increased 19.8 percent to 375.3 billion won. (Yonhap)
The company said in a regulatory filing that operating income for the October-December period fell 13.4 percent on-year to 92.6 billion won. Sales increased 19.8 percent to 375.3 billion won. (Yonhap)
